BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

«Venombin A

Below is an extended Venombin A research listing. Click here to return to the Venombin A main in depth entry.

Recent Publications on Venombin A:

Effect of hemocoagulase for prevention of pulmonary hemorrhage in critical newborns on mechanical ventilation: a randomized controlled trial. 11th July, 2008
Department of Pediatrics, Research Institute of Surgery and Daping
GlycoWorkbench: a tool for the computer-assisted annotation of mass spectra of glycans.
Mass spectrometry is the main analytical technique currently used to...
Direct Link
24th June, 2008
Division of Molecular Biosciences, Imperial College London, London SW72AZ,
Platelet-rich plasma and platelet gel preparation using Plateltex.
BACKGROUND: The platelet gel is made by embedding concentrate platelets...
Direct Link
1st May, 2008
Blood Transfusion Centre and Biotechnology Laboratory, Ospedale SS Antonio
B:b interactions are essential for polymerization of variant fibrinogens with impaired holes 'a'.
BACKGROUND: Fibrin polymerization is mediated by interactions between...
Direct Link
9th January, 2008
Laboratory of Clinical Chemistry, Department of Biomedical Laboratory
Which knobs fit into which holes in fibrin polymerization?
BACKGROUND: Fibrin polymerization is mediated by interactions between...
Direct Link
9th January, 2008
Department of Cell and Developmental Biology, University of Pennsylvania
Role of 'B-b' knob-hole interactions in fibrin binding to adsorbed fibrinogen.
BACKGROUND: The formation of a fibrin clot is supported by multiple...
Direct Link
9th January, 2008
Department of Chemistry, University of North Carolina, Chapel Hill, NC
Expression and purification of ancrod, an anticoagulant drug, in Pichia pastoris.
Ancrod is known as a thrombin-like enzyme from the venom of Calloselasma...
Direct Link
8th January, 2008
Beijing Institute of Biotechnology, 20 Dong Da Street, Fengtai District,
Identification and characterization of Harobin, a novel fibrino(geno)lytic serine protease from a sea snake (Lapemis hardwickii).
A gene encoding a novel serine protease designated as Harobin is cloned...
Direct Link
19th August, 2007
National Key Laboratory of Protein Engineering, LSC, Peking University,
Feasibility of treating hyperfibrinogenemia with intermittently administered batroxobin in patients with ischemic stroke/transient ischemic attack for secondary prevention.
This study evaluated the safety and efficacy of batroxobin in treating...
Direct Link
17th May, 2007
Department of Neurology, Jinling Hospital, Nanjing University School of
Alternative anticoagulation management strategies for the patient with heparin-induced thrombocytopenia undergoing cardiac surgery.
A gene encoding a novel serine protease designated as Harobin is cloned...
Direct Link
1st May, 2007
Department of Anesthesiology, Evanston Northwestern Healthcare,
[Effect of batroxobin on K+ channel activated by Ca2+ in primary culture rat cortex neurons of rat] 31st March, 2007
Department of Neurology, West China Hospital, Sichuan University, Chengdu
A novel nuclear interactor of ARF and MDM2 (NIAM) that maintains chromosomal stability.
The ARF tumor suppressor signals through p53 and other poorly defined...
Direct Link
8th March, 2007
Department of Pharmacology, Roy J. and Lucille A. Carver College of
A coagulation factor VII deficiency protects against acute inflammatory responses in mice.
Upregulation of the activated Factor VII (FVIIa)/Tissue Factor complex,...
Direct Link
18th January, 2007
WM Keck Center for Transgene Research, University of Notre Dame, Notre
Intravenous ancrod for acute ischaemic stroke in the European Stroke Treatment with Ancrod Trial: a randomised controlled trial.
BACKGROUND: Intravenous tissue plasminogen activator is the only approved...
Direct Link
9th December, 2006
Department of Neurology, University of Heidelberg, Universitatsklinikum
[Batroxobin in patients with ischemic stroke in the carotid system (the multicenter study)] 13th October, 2006
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional